<DOC>
	<DOCNO>NCT00387387</DOCNO>
	<brief_summary>This study test safety treat colorectal cancer combination drug . The current standard treatment FOLFOX6 CapeOx give combination GSK investigational drug pazopanib .</brief_summary>
	<brief_title>Study On Pazopanib When Given With FOLFOX6 ( Fluorouracil , Oxaliplatin , Leucovorin ) Or CapeOx ( Capecitabine , Oxaliplatin )</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Diagnosis locally advance metastatic colorectal cancer . No prior chemotherapy metastatic disease . Presence radiologically and/or clinically documented disease . Eastern Cooperative Oncology Group performance status 0 1 . Adequate bone marrow , hepatic , renal function , Urine Creatinine Ratio ( UPC ) &lt; A female subject must pregnant breast feeding . Able swallow retain oral medication . Has major surgery , chemotherapy , hormone therapy , investigational agent , radiotherapy within last 28 day Prior treatment pazopanib , oxaliplatin . Known contraindication use oxaliplatin , capecitabine , 5fluorouracil , folinic acid . Participation investigational study within 28 day prior study treatment . Women pregnant lactating . Poorly control hypertension . A history cardiovascular disease , arrhythmia , significant ECG abnormality . Any history stroke . Current use therapeutic warfarin . Known brain metastasis . History disease significantly affect gastrointestinal function major resection stomach small bowel . Active infection serious illness . History allergy platinum compound heparin . Poor venous access .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>colorectal cancer</keyword>
	<keyword>pazopanib</keyword>
	<keyword>capecitabine</keyword>
	<keyword>CapeOx</keyword>
	<keyword>5-fluorouracil</keyword>
	<keyword>oxaliplatin</keyword>
	<keyword>combination therapy</keyword>
	<keyword>FOLFOX 6</keyword>
</DOC>